oncology

Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology
Flag link:
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Rain Oncology
layoffs
clinical trials
milademetan
oncology
solid tumors
Flag link:
Takeda puts $510M on the line to expand KSQ cancer collaboration
Takeda puts $510M on the line to expand KSQ cancer collaboration
Fierce Biotech
Takeda
KSQ Therapeutics
cancer
oncology
Flag link:
Astellas, Sony Team on Novel ADC Platform for Oncology
Astellas, Sony Team on Novel ADC Platform for Oncology
BioSpace
Astellas
Sony Corporation
antibody-drug conjugate
oncology
Flag link:
Why Shares of Cassava Sciences Jumped Last Week
Why Shares of Cassava Sciences Jumped Last Week
Motley Fool
Cassava Sciences
Simulfilam
oncology
cancer
Flag link:
This Startup Just Raised $90M To Fight Cancer
This Startup Just Raised $90M To Fight Cancer
Crunchbase
Convergent Therapeutics
funding
oncology
radiopharmaceuticals
prostate cancer
Flag link:
White House rolls out new cancer initiative to help implement ‘Moonshot’
White House rolls out new cancer initiative to help implement ‘Moonshot’
The Hill
cancer
oncology
White House
cancer moonshot
Flag link:
OncoRix's breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model
OncoRix's breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model
BioSpace
OncoRix
breast cancer
oncology
Flag link:
Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B
Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B
BioSpace
Bicycle Therapeutics
Novartis
drug discovery
oncology
radioligand
Flag link:
AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug
AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug
Fierce Biotech
AbbVie
CytomX Therapeutics
cancer
oncology
antibody-drug conjugate
Flag link:
Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs
Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs
Medical Marketing and Media
FDA
clinical trials
cancer
oncology
accelerated approvals
Flag link:
FDA floats oncology authorization shake-up, pitching 'one-trial' model for accelerated and full approval
FDA floats oncology authorization shake-up, pitching 'one-trial' model for accelerated and full approval
Fierce Biotech
FDA
oncology
regulatory
Flag link:
BioNTech signs deal to co-develop OncoC4's cancer drug
BioNTech signs deal to co-develop OncoC4's cancer drug
Reuters
BioNTech
OncoC4
cancer
oncology
drug development
ONC-392
Flag link:
BioXcel takes surprising path with IPO of oncology spinout OnkosXcel
BioXcel takes surprising path with IPO of oncology spinout OnkosXcel
Fierce Biotech
BioXcel
IPOs
oncology
OnkosXcel
Flag link:
Exscientia builds cancer pipeline with two BMS drugs
Exscientia builds cancer pipeline with two BMS drugs
Pharmaphorum
Exscientia
Bristol Myers Squibb
oncology
EXS73565
EXS74539
Flag link:
The state of the oncology microbiome therapeutics pipeline at a glance
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
oncology
cancer
microbiome
drug development
Flag link:
Lantern Pharma announces plans to enhance oncology drug discovery
Lantern Pharma announces plans to enhance oncology drug discovery
Outsourcing Pharma
Lantern Pharma
drug discovery
oncology
machine learning
artificial intelligence
Flag link:
On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Fierce Biotech
Corbus Pharmaceuticals
Seagen
Padcev
CRB-701
oncology
Flag link:
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
Xtalks
clinical trials
Medable
Nova Scotia
oncology
decentralized clinical trials
Flag link:
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Endpoints
TILT Biotherapeutics
oncolytic viruses
clinical trials
cancer
oncology
Flag link:

Pages